The influence of osteolytic substances on the production of osseous metastases from Walker 256 sarcoma in rats.
D000818:Animals; D001859:Bone Neoplasms / Q000473:pathology*; D001862:Bone Resorption / Q000139:chemically induced*; D001842:Bone and Bones / Q000187:drug effects; D002279:Carcinoma 256, Walker / Q000473:pathology*; D004875:Ergosterol / Q000494:pharmacology; D006934:Hypercalcemia / Q000139:chemically induced* / Q000150:complications; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008113:Liver Neoplasms / Q000473:pathology; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology; D009362:Neoplasm Metastasis; D010281:Parathyroid Hormone / Q000494:pharmacology; D051381:Rats
D010281:Parathyroid Hormone; D008775:Methylprednisolone; D004875:Ergosterol